Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa: The ANRS 12286/MOBIDIP trial

Category Primary study
ConferenceJournal of the International AIDS Society
Year 2016
This article has no abstract
Epistemonikos ID: b95ef0b31725492f4aa6c58f0e654e621d1e0cde
First added on: Apr 29, 2026